Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
about
Current status of biomarkers for prostate cancerNovel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.Personalized management in low-risk prostate cancer: the role of biomarkers.Novel biomarkers for the detection of prostate cancer.Engrailed homeobox transcription factors as potential markers and targets in cancer.Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection.EN2: a novel prostate cancer biomarker.Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.Engrailed-2 might play an anti-oncogenic role in clear-cell renal cell carcinoma.Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.Hsa-miR-27b is up-regulated in cytomegalovirus-infected human glioma cells, targets engrailed-2 and inhibits its expression.Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer.Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.Engrailed-2 promoter hyper-methylation is associated with its downregulation in clear cell renal cell carcinoma.Urinary EN-2 to predict prostate cancer: Systematic review and meta-analysis.Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma.Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer
P2860
Q24600574-C031D0C2-D30F-40EC-BB0F-B674F36C06CBQ34285190-A9F09C2C-7B8D-42C2-AC66-666A4FEF68BBQ35460015-C19E9438-08CB-4F91-90E4-F2987CDEA60BQ36495701-5C1562A3-3E0F-4AD8-91A2-482BD1BD5F90Q37708174-0D84248D-7ECD-4881-8E97-6D76D9BB2904Q38080336-895B8745-B7EE-421B-A82F-F6250DB43522Q38128377-670DD984-4F51-48DB-AD6B-BA7C3EBC92A7Q38165246-9FFFC07B-7DD2-490C-9A84-5E47E2EB6968Q38613772-7E064265-C510-47A7-8EB3-B4C382A690BDQ38762770-174F3CF1-BEDB-4F60-ADAE-CEB5439BAD97Q38854599-CD146FEF-9F7F-41C6-A1B6-9BEB8BF29438Q38875885-732B72D8-64CE-4F35-8577-CD38ED08678FQ40707371-A63C5D5C-AA43-464A-A876-9A42B74C5FEFQ43052119-A311A93B-0059-43DE-9C31-0A09ED98F605Q47171569-041A0F99-C086-4A31-9C9C-F3F4BB65C315Q47700631-499C9785-3A6E-49A9-84EA-50D8DE5FC614Q53242019-06E386F1-8B55-485E-829D-FD8FA41D2C58Q57694335-D52245D9-FC0E-4197-A0AC-F1311A59DD9F
P2860
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Urinary engrailed-2 (EN2) leve ...... tatectomy for prostate cancer.
@en
type
label
Urinary engrailed-2 (EN2) leve ...... tatectomy for prostate cancer.
@en
prefLabel
Urinary engrailed-2 (EN2) leve ...... tatectomy for prostate cancer.
@en
P2093
P2860
P1433
P1476
Urinary engrailed-2 (EN2) leve ...... statectomy for prostate cancer
@en
P2093
Hardev Pandha
Michael Borre
Soren Hoyer
Stephen Langley
Thorsten F Orntoft
P2860
P304
P356
10.1111/J.1464-410X.2012.11208.X
P433
P577
2012-05-15T00:00:00Z